Status
Conditions
Treatments
About
The overarching aim of our study is to assess the incidence of dose reduction and discontinuations for pirfenidone and nintedanib.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
2,778 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal